INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a …
SW Majoni, J Nelson, D Germaine, L Hoppo, S Long… - Trials, 2021 - Springer
Background The effectiveness of erythropoiesis-stimulating agents, which are the main stay
of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate …
of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate …
Comparison of ferric carboxymaltose and iron polymaltose efficacy in renal anaemia
G Allen, P Hakendorf, A Kruger… - Renal Society of …, 2018 - search.informit.org
Thirty chronic kidney disease (CKD) patients were retrospectively analysed at the Flinders
Medical Centre, having received both iron polymaltose (IP) and ferric carboxymaltose (FCM) …
Medical Centre, having received both iron polymaltose (IP) and ferric carboxymaltose (FCM) …
Iron polymaltose use in chronic kidney disease patients: one unit's experience.
A Lee - Renal Society of Australasia Journal, 2009 - search.ebscohost.com
Background: A major concern of iron therapy is the safety and related adverse events, in
particular, the association of iron therapy to anaphylactic reactions. Aim: To report adverse …
particular, the association of iron therapy to anaphylactic reactions. Aim: To report adverse …
Experience with the use of an iron polymaltose (dextrin) complex given by single total dose infusion to stable chronic haemodialysis patients
R van Zyl-Smit, JA Halkett - Nephron, 2002 - karger.com
Background: Many studies of anaemia in patients on chronic haemodialysis have noted a
high prevalence of iron deficiency despite oral iron supplementation. Our study examined …
high prevalence of iron deficiency despite oral iron supplementation. Our study examined …
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
GR Bailie, M Larkina, DA Goodkin, Y Li… - Nephrology Dialysis …, 2013 - academic.oup.com
Background To examine patterns of intravenous (IV) iron use across 12 countries from 1999
to 2011. Methods Trends in iron use are described among 32 192 hemodialysis (HD) …
to 2011. Methods Trends in iron use are described among 32 192 hemodialysis (HD) …
[PDF][PDF] Iron therapy in patients with chronic kidney disease: taking the high road
WH Hörl - Port J Nephrol Hypert, 2009 - bbg01.com
∎ ABSTRACT Iron deficiency is common in patients with chronic kidney disease (CKD) as a
result of stimulated erythropoiesis, reduced dietary iron intake, inhibition of intestinal iron …
result of stimulated erythropoiesis, reduced dietary iron intake, inhibition of intestinal iron …
Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney disease
SW Majoni, J Nelson, J Graham, A Abeyaratne… - BMC nephrology, 2023 - Springer
Background Ferritin levels are used to make decisions on therapy of iron deficiency in
patients with chronic kidney disease (CKD). Hyperferritinaemia, common among patients …
patients with chronic kidney disease (CKD). Hyperferritinaemia, common among patients …
[HTML][HTML] Options for intravenous iron supplementation in hemodialysis patients
JY Kong, HS Hwang - Kidney research and clinical practice, 2020 - ncbi.nlm.nih.gov
Kidney Res Clin Pract 2020; 39 (3): 239-243 pISSN: 2211-9132• eISSN: 2211-9140
https://doi. org/10.23876/j. krcp. 20.140 240 www. krcp-ksn. org stress and systemic …
https://doi. org/10.23876/j. krcp. 20.140 240 www. krcp-ksn. org stress and systemic …
SO051 PROSPECTIVE OPEN-LABEL EXPLORATIVE RANDOMISED SINGLE CENTRE COMPARATIVE STUDY TO DETERMINE THE EFFECTS OF VARIOUS …
X Kassianides, A Zeidan… - Nephrology Dialysis …, 2020 - academic.oup.com
Abstract Background and Aims Iron deficiency in Chronic Kidney Disease (CKD) is common.
It frequently necessitates the use of intravenous (IV) iron for correction. A number of second …
It frequently necessitates the use of intravenous (IV) iron for correction. A number of second …
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
IC Macdougall - Current medical research and opinion, 2010 - Taylor & Francis
Background: The management of iron-deficiency anaemia in patients with non-dialysis
chronic kidney disease (ND-CKD) remains controversial, particularly regarding the use of …
chronic kidney disease (ND-CKD) remains controversial, particularly regarding the use of …